Marc A. Recht
T: +1 617 937 2316
mrecht@cooley.com
January 22, 2015
United States Securities and Exchange Commission |
FOIA CONFIDENTIAL |
Division of Corporation Finance |
TREATMENT REQUEST |
Mail Stop 6010
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jeffrey P. Riedler
Preston P. Brewer
Re: Flex Pharma, Inc.
Registration Statement on Form S-1
File No. 333-201276
Dear Mr. Riedler:
We are writing on behalf of our client, Flex Pharma, Inc. (the Company), pursuant to 17 C.F.R. § 200.83 to request confidential treatment for the indicated portions of the following document:
Letter from Cooley LLP to the United States Securities and Exchange Commission, dated January 22, 2015, attached hereto as Exhibit A.
We hereby request, pursuant to 17 C.F.R. § 200.83 that the selected portions of the attached letter (indicated by brackets and yellow highlighting) be maintained in confidence, not be made part of any public record and not be disclosed to any person as it contains confidential information, which would be competitively harmful to the Company if disclosed publicly. In accordance with 17 C.F.R. § 200.83(d)(1), if any person (including any governmental employee who is not an employee of the Securities and Exchange Commission) should request access to or an opportunity to inspect this letter, we request that we be immediately notified of any such request, be furnished with a copy of all written materials pertaining to such request (including, but not limited to, the request itself) and be given at least ten (10) business days advance notice of any intended release so that the Company may, if deemed necessary or appropriate, pursue any remedies available to it. In such an event, we request that you telephone me, the responsible representative, at (617) 937-2316, rather than rely upon U.S. mail for such notice. My address is c/o Cooley LLP, 500 Boylston Street, Boston, MA 02116.
***********
500 BOYLSTON STREET, BOSTON, MA 02116-3736 T: (617) 937-2300 F: (617) 937-2400 WWW.COOLEY.COM
Securities and Exchange Commission
Division of Corporation Finance
January 22, 2015
Page Two
Please acknowledge receipt of this request for confidential treatment by file-stamping the enclosed copy of this request and returning it to the undersigned in the self-addressed stamped envelope provided. If you have any questions or comments, or would like additional information regarding the enclosed, please contact me at (617) 937-2316.
Sincerely,
Cooley LLP
/s/ Marc A. Recht
Marc A. Recht, Esq.
Enclosure
cc: Robert O. Hadfield, Esq., Flex Pharma, Inc.
Nathan Ajiashvili, Esq., Latham & Watkins LLP
cc (w/o encl.): Office of Freedom of Information and Privacy Act Operations
Securities and Exchange Commission
Operations Center
6432 General Green Way
Alexandria, VA 22312-2413
500 BOYLSTON STREET, BOSTON, MA 02116-3736 T: (617) 937-2300 F: (617) 937-2400 WWW.COOLEY.COM
Marc A. Recht
T: +1 617 937 2316
mrecht@cooley.com
EXHIBIT A
LETTER FROM COOLEY LLP TO THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION
DATED JANUARY 22, 2015